About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, December 16th, 2015

The QualityStocks
Daily Stock List


EMS Find, Inc. (EMSF)

Today we are reporting on EMS Find, Inc. (EMSF), here at the QualityStocks Daily Newsletter.

OTCQB-listed EMS Find, Inc. develops state-of-the-art health care solutions. The Company develops and markets a B2B (Business-to-Business) and B2C (Business-to-Consumer) on-demand mobile platform designed to connect health care providers and consumers to a network of medical transport companies throughout the U.S. and Canada. Its solution facilitates, speeds up and connects health care providers and the public with ambulance providers for the benefit of the patients. EMS Find is based in Philadelphia, Pennsylvania.

Its platform enables hospitals, medical offices, dialysis centers, nursing homes, home care agencies and other medical providers, and the public to schedule medical transportation in a timely and efficient way based on the type of medical transportation that best fits each patient's needs.

The EMS Find app will work on any smart device. Android, iOS and desktop versions will permit users to connect in real time to local and nearby pre-screened medical transportation companies wherever the medical transports are required and fit the medical, logistical, as well as financial criteria.

EMS Find has signed a Letter Of Intent (LOI) to acquire Page Out. This is an interactive platform designed to streamline the emergency response process. It provides management with real time status on where and when team members are responding to emergency and dispatch.
EMS Find announced this past July its intention to expand the EMS Find Application through starting development of the RN Find on-demand mobile platform. The design of it is to connect hospitals, nursing homes, home care agencies and other health care providers with nursing professionals who are looking for additional employment. The design of it is also to assist patients looking for assistance with post-acute and sub-acute health care.

Recently, EMS Find announced that the EMS Find iOS App was approved by Apple for release. EMS Find App is a cloud-based on-demand platform. It is used with smartphones and web technologies to offer optimal booking, scheduling and dispatching for non-emergent medical transports.

Last month, EMS Find announced the creation of Viva Entertainment Group (VEG). This is a wholly-owned subsidiary with a focus on developing and marketing its technology, and delivering content, subscription TV services to an array of smart devices including connected TVs, streaming media players, smartphones and tablets featuring Over The Top (OTT) technology.

EMS Find, Inc. (EMSF), closed Wednesday's trading session at $0.3696, up 15.86%, on 76,610 volume with 28 trades. The average volume for the last 60 days is 38,175 and the stock's 52-week low/high is $0.2801/$2.53.

Dais Analytic Corp. (DLYT)

SmallCapVoice, StockRich, StockEgg, MadPennyStocks, BullRally, PennyInvest, HotOTC, PennyStockVille, CoolPennyStocks, Stockpalooza, Money Morning, and Penny Stock Rumble reported previously on Dais Analytic Corp. (DLYT), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Dais Analytic Corp. is a nanotechnology materials and process company centering on commercializing its technology in the global energy and water markets. It provides industry-changing, nanotechnology-based applications for heating & cooling, water treatment, and energy storage. The Odessa, Florida-based Company is commercializing its inventive Aqualyte™ family of nano-structured materials and processes focusing on disruptive air, energy, and water applications.

The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™, a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product); and NanoAir™, which is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle.

Uses also include NanoClear™, which is an early beta-stage method for treating contaminated water to provide 1,000 times cleaner potable water. The NanoClear™ process has consistently shown Dais Analytic’s novel Aqualyte® material can separate most contaminants from water, attaining nearly 'parts per billion' clean product water with little or no fouling of the essential membrane component.

Uses also include NanoCAP™. Dais Analytic indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive non-chemical energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, and 'smart grid' configurations.

Dais Analytic announced in 2014 that it entered into a definitive agreement with SoEX (Hong Kong) Industry & Investment Co. to create a People’s Republic of China (PRC) company, owned by both parties, to construct and sell Dais's ConsERV™ High Efficiency Energy Recovery Ventilator (ERV) into the greater China market and select use of Dais’ Aqualyte™ nanomaterial to clean up contaminated water. SoEX Hong Kong has an established manufacturing and distribution network.

Dais Analytic announced in October 2014 that SoEX (Beijing) Environmental Protection Technology Co., Ltd. a joint venture owned by Dais and SoEX (Hong Kong) Industry & Investment Co., Ltd., began production and distribution of the Company's ConsERV Energy Recovery Ventilator (ERV) product in China.

Additionally, in October, Dais Analytic announced it successfully completed the testing of a new generation of safer, more efficient cooling tower technology it calls "PolyCool™" utilizing the features of Its Aqualyte™ nanomaterial.

Dais Analytic Corp. (DLYT), closed Wednesday's trading session at $0.165, up 62.88%, on 200 volume with 1 trade. The average volume for the last 60 days is 8,370 and the stock's 52-week low/high is $0.10/$0.34.

Rx Safes, Inc. (RXSF)

PREPUMP STOCKS, Penny Stock Newsletter, Damn Good Penny Picks, Penny Picks, SmallCapVoice, and Shiznit Stocks reported on Rx Safes, Inc. (RXSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rx Safes, Inc. is the developer of patented autonomous fingerprint healthcare security products. The Company is an emerging leader in the personal and professional healthcare drug security marketplace. Its products integrate proprietary patented fingerprint technology to provide drug security solutions for use in homes and healthcare facilities. OTC Bulletin Board-listed, Rx Safes is headquartered in Henderson, Nevada.

The corporate mission of the Company is to become the foremost provider of autonomous fingerprint medical security solutions for the professional healthcare and consumer markets. Its team has more than 30 years of experience in designing and manufacturing fingerprint security products. This team has been innovators in the development and commercialization of embedded fingerprint consumer products. The Founders of Rx Safes have been innovators in the fingerprint recognition space for over two decades.

The Company designs autonomous fingerprint recognition and authentication technology. It incorporates this technology into products to secure drugs and improve medication adherence. Rx Safes designs, develops, manufactures and integrates stand-alone technology that utilizes one’s finger as a key. Its Patented Fingerprint Technology keeps all of one’s medications and equipment secure and safe.

Rx Safes’ technology is user-friendly. It does not store any personal data; it does not store a copy of one’s fingerprint either.  All of the Company’s products are stand-alone –they are all self powered – battery operated. There is no way to break into the product to steal one’s data. Rx Safes’ patent covers the processing speed, matching time as well as size of the data collected for the matching process. This is all driven by at least one battery.

Last month, Rx Safes announced that it acquired another patent, which further expands its intellectual property (IP) portfolio, protecting its Rx SafeDOSE, Patient Controlled Analgesia pendant. The patent inventor, Mr. Phillip Jurson, MD., is a nationally renowned anesthesiologist and pain management physician. Mr. Jurson was awarded patent number 7,806,852 - method and apparatus for patient-controlled medical therapeutics utilizing biometrics in a patient controlled administration of pain medications, with a priority date in April 2006. The patent strengthens Rx Safes’ IP surrounding its Rx SafeDOSE product.

Rx Safes, Inc. (RXSF), closed Wednesday's trading session at $1.85, up 15.62%, on 6,288 volume with 19 trades. The average volume for the last 60 days is 149 and the stock's 52-week low/high is $0.22/$200.00.

ABCO Energy, Inc. (ABCE)

Today we are reporting on ABCO Energy, Inc. (ABCE), here at the QualityStocks Daily Newsletter.

Established in 2008, ABCO Energy, Inc. is an Arizona licensed contractor for the sales and installation of Photovoltaic Solar Systems, Solar Street Lighting and the installation of LED and energy conservation lighting systems in its markets. The Company provides products and services to residential, commercial, government and non-profit entities in all of its markets.

ABCO Energy has offices in Tucson, Phoenix and Flagstaff, Arizona and its shares trade on the OTC Markets Group’s OTCQB. ABCO Solar is a partner with ABCO Energy. ABCO Solar is a full-service, licensed electrical contractor. It helps its clients’ with every stage of their solar panel installation. This is from ascertaining the size, financing options, tax and utility incentives.

ABCO Energy sells and installs solar photovoltaic electric systems, which enable customers to produce power on their residence or business property. In addition, the Company sells and installs energy efficient lighting products, solar powered street lights, and lighting accessories to residential and commercial customers. Furthermore, it offers solar leasing and long term financing programs to its customers and other marketing and installation organizations.

In August of this year, ABCO Energy announced the highest backlog of commercial and residential solar installation work in its history.  With considerable commercial financing available, ABCO Energy was able to secure contracts that carry it through the 2015 year with profitable work.

The Company signed a solar electric system installation contract on July 2, 2015 to build solar projects on four commercial locations in Arizona for an organization that owns a number of self-storage facilities in Arizona and California.  This contract totals $1,200,000 and is fully funded.

Today, ABCO Energy announced the completion of a 70,560 Watt DC voltage first phase and another smaller project of 22,500 Watt DC of its backlogged commercial solar projects. The system will provide shaded parking for up to 48 recreational vehicles. All steel components were constructed by Park N Shade steel contractors (Tucson, Arizona). ABCO Energy completed all solar system components, system design, permitting as well as electrical interconnection to set this system online in December 2015.

ABCO Energy, Inc. (ABCE), closed Wednesday's trading session at $0.07, up 75.00%, on 208,250 volume with 10 trades. The average volume for the last 60 days is 5,493 and the stock's 52-week low/high is $0.01/$0.72.

U.S. Stem Cell, Inc. (USRM)

Today we are reporting on U.S. Stem Cell, Inc. (USRM), here at the QualityStocks Daily Newsletter.

Established in 1999, U.S. Stem Cell, Inc. is a leader in the regenerative medicine/cellular therapy industry. The OTCQB-listed Company is a developer of novel autologous cell therapies, and a provider of physician based stem cell therapies to human and animal patients. U.S. Stem Cell has its corporate head office in Sunrise, Florida.

The Company was previously known as Bioheart, Inc. It changed its name to U.S. Stem Cell, Inc. this past October. Its emphasis is on the discovery, development and commercialization of cell based therapeutics that prevent, treat or cure disease through repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

The Company has three operating divisions: US Stem Cell Training, Vetbiologics, and US Stem Cell Clinic. U.S. Stem Cell’s business includes the development of proprietary cell therapy products and revenue generating physician and patient based regenerative medicine/cell therapy training services, cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and also the operation of a cell therapy clinic.

Earlier this month, U.S. Stem Cell announced that it successfully completed five physician based treatments of traumatic brain injury (TBI) patients. The five patients, who received stromal vascular fraction from adipose tissue delivered intrathecally, have been treated over the past 12 months at the U.S. Stem Cell Clinic in Sunrise, Florida.

Moreover, this month, U.S. Stem Cell announced the completion of its name change with its new trading symbol - USRM. In addition, it completed a financing transaction with Magna Equities II, LLC.

U.S. Stem Cell President and Chief Executive Officer, Mr. Mike Tomas, stated, "We are pleased to continue our financial partnership with Magna who continues to believe in and support our strategic building plan. We also deeply appreciate our shareholder support in the actions we have and are taking to build U.S. Stem Cell into a world class company."

U.S. Stem Cell, Inc. (USRM), closed Wednesday's trading session at $1.00, down 8.26%, on 12,544 volume with 39 trades. The average volume for the last 60 days is 3,650 and the stock's 52-week low/high is $0.25/$22.90.


The QualityStocks
Company Corner


Nutra Pharma Corp. (NPHC)

The QualityStocks Daily Newsletter would like to spotlight Nutra Pharma Corp. (NPHC). Today, On the Move Systems, Inc. closed trading at $0.084, up 0.48%, on 1,064,665 volume with 46 trades. The stock’s average daily volume over the past 60 days is 183,394, and its 52-week low/high is $0.0025/$0.27.

Nutra Pharma Corp. was announced today by QualityStocks as having a new audio interview with Rik Deitsch, CEO of NPHC made available. The interview can be heard HERE. Nutra Pharma is developing a broad product platform for numerous indications, and it currently has 21 patents in its intellectual property portfolio.

Nutra Pharma Corp. (NPHC) is a biotech company working in collaboration with its subsidiaries to develop an innovative pipeline of biopharmaceutical products for the management of neurological disorders, cancer, autoimmune, and infectious diseases. At the core of Nutra Pharma's intellectual property is a unique platform for extracting neurotoxins from Asian cobra venom and transforming them into non-toxic therapeutics.

The ReceptoPharm subsidiary, Nutra Pharm's drug discovery arm, is focused on the development of new therapeutic agents based upon specialized receptor-binding proteins found in nature, especially those found in snake venom from the cobra. ReceptoPharm's R&D pipeline consists of several novel therapies in various stages of development to prevent and/or treat multiple sclerosis (MS), human immunodeficiency virus (HIV), adrenomyeloneuropathy (AMN), herpes, rheumatoid arthritis (RA) and pain. The subsidiary also provides small and start-up biotech companies a full range of contract research services through its ISO class 5 and GMP certified facilities in Plantation, Florida.

Nutra Pharma recently received Orphan Drug Status from the FDA for the treatment of pediatric MS for its drug, RPI-78M. The designation of RPI-78M as an Orphan Drug provides Nutra Pharma with a seven-year period of market exclusivity in the U.S. once the drug is approved. Additional benefits over conventional drug applications include: tax credits for clinical research costs, the ability to apply for grant funding, clinical trial design assistance, plus assistance from the FDA in the drug development process and the waiver of Prescription Drug User Fee Act (PDUFA) filing fees which could be in excess of $2.5 million. The granting of Orphan Drug Designation allows Nutra Pharma to move forward with its preparation of an Investigative New Drug Application and proposal of clinical trials. The FDA grants Orphan Drug Designation status to products that treat rare diseases, providing incentives to sponsors developing drugs or biologics.

ReceptoPharm holds all of the intellectual property for Nutra Pharma's drug pipeline, while Nutra Pharma directly holds all of the property dealing with their over-the-counter drugs. This includes Nyloxin, an OTC pain reliever for humans, and Pet Pain-Away, a pain reliever for dogs and cats. The company's Nyloxin product is the first OTC pain reliever clinically proven to treat moderate to severe chronic pain. The drug is available as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

Nutra Pharma is a revenue-generating company with 12 patents and patents pending, three completed phase 1/phase 2 clinical trials, and 12 FDA-registered OTC products in the United States. The company also has regulatory clearance for Nyloxin in India, where management believes its initial distribution streams could become the company's biggest market. Management is also defining its plan to expand into China and Canada while strengthening its position the United States. Disclaimer

Nutra Pharma Corp. Company Blog

Nutra Pharma Corp. News:

Nutra Pharma Corp. (NPHC) CEO Featured in Exclusive QualityStocks Interview

Nutra Pharma Corp. (NPHC) Announces Engagement of QualityStocks Corporate Communications Suite

Nutra Pharma Announces Additional Orphan Drug Application for RPI-78M for the Treatment of Myasthenia Gravis

Legacy Ventures International, Inc. (LGYV)

The QualityStocks Daily Newsletter would like to spotlight Legacy Ventures International, Inc. (LGYV). Today, Legacy Ventures International, Inc. closed trading at $1.60, up 5.96%, on 133,327 volume with 281 trades. The stock’s average daily volume over the past 60 days is 27,843, and its 52-week low/high is $0.01/$2.50.

Legacy Ventures International, Inc. was pleased to announce today that media/technology venture capitalist Mr. G Scott Paterson has joined the Advisory Committee of Legacy Ventures. Mr. Paterson serves as chairman of Symbility Solutions Inc., a cloud-based SaaS provider of software to the insurance industry; chairman of Engagement Labs Inc., a cloud-based SaaS provider of software for marketers; a director and chair of the Audit & Risk Committee of Lions Gate Entertainment, a mini major film and television studio; and chairman of QYOU Media Inc., a PayTV service available in over 20 countries in EMEA showcasing the world's best made-for-the-web short form content.

Legacy Ventures International, Inc. (LGYV) is an investment company seeking out high-potential businesses with big ideas that can be scaled in order to promote hyper growth. The company fuels innovation and passion by providing the capital, oversight and connections that young businesses need to reach their full potential.

Legacy is led by a highly-qualified executive team with decades of relevant industry experience. Evan Clifford, the company's chief executive officer, has spent more than 15 years building and maintaining relationships with some of North America's most influential executives. Over the past decade, he has served as a lead advisor to a collection of companies and individuals striving for personal and professional success. Likewise, Rehan Saeed, Legacy's chief financial officer, has over a decade of experience in the banking industry during which he built and managed a real estate portfolio valued at $110 million.

The company's current brand portfolio is headlined by newly-acquired RM Fresh Brands, a servicer of food and beverage retailers and distributors around the globe. RM Fresh Brands takes a unique approach to brand partnerships by maintaining a clear focus on sustainable, category-changing consumables. This strategy has helped it build an extensive portfolio of highly-desirable brands – including Boxed Water, Aloe Gloe, Uncle Si's Iced Tea and Chef 5-Minute Meals.

Following the successful acquisition of RM Fresh Brands, Legacy is in a strong strategic position to move forward with its efforts to promote sustainable growth. The company will lean on the considerable experience of its management team as it looks to build on its recent progress while promoting maximized shareholder value. Disclaimer

Legacy Ventures International, Inc. Company Blog

Legacy Ventures International, Inc. News:

Legacy Ventures Welcomes G. Scott Paterson to the Advisory Committee

Legacy Ventures International Due Diligence Report: Being Green is in; Boxed Water a Step Closer to Reducing the Carbon Footprint

Legacy Ventures Subsidiary RM Fresh Brands Completes Agreement to Supply Products to Sysco for Distribution

Cherubim Interests, Inc. (CHIT)

The QualityStocks Daily Newsletter would like to spotlight Cherubim Interests, Inc. (CHIT). Today, Cherubim Interests, Inc. closed trading at $0.00039, up 105.26%, on 313,889,724 volume with 148 trades. The stock’s average daily volume over the past 60 days is 40,234,171, and its 52-week low/high is $0.0001/$0.33.

Cherubim Interests, Inc. (CHIT) is a development-stage alternative construction and real estate development company seeking various opportunities relative to the company's management team of experts in property management, construction and finance.

The company's primary focus is within the real estate development and controlled environment agriculture sectors, which Cherubim recently entered into by acquiring an exclusive worldwide license for the deployment of a proprietary plant cultivation technology. Through its wholly owned subsidiary, BudCube Cultivation Systems USA, Cherubim plans to construct, deploy and lease scalable medical and recreational marijuana cultivation facilities for commercial applications.

Coupled with a real estate development and property management business model, BudCube Cultivation Systems ("BCS") can position itself anywhere in the world where the cultivation of cannabis is legal. BCS's unique business model positions the company to greatly benefit as more market participants seek to gain entry into a fast-growing market at an attractive price point.

Armed with the ability to lease a portable and scalable turn-key cultivation solution to growers, Cherubim aims to use its licensed solution to fill the gap for both first-time and experienced cultivators who may not have the capital resources to buy land, construct or tenant-improve existing structures for the optimum environment for developing a high-quality cannabis product. Disclaimer

Cherubim Interests, Inc. Company Blog

Cherubim Interests, Inc. News:

Cherubim Interests, Inc. Announces End of Year Convertible Preferred Stock Dividend

Cherubim Interests (CHIT) Signs MOU With United Cannabis Corp. (CNAB)

Cherubim Interests, Inc. Goes Long with its Shareholders

OurPet's Company (OPCO)

The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $0.94, up 11.90%, on 8,379 volume with 5 trades. The stock’s average daily volume over the past 60 days is 6,219, and its 52-week low/high is $0.45/$1.00.

OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.

In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.

The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.

OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer

OurPet's Company Company Blog

OurPet's Company News:

Dean Tsengas Named Chief Operations Officer of OurPet's Company

OurPet's Company (OPCO) Named 'Company of the Month' in November Issue of The Bowser Report

OurPet's Company Reports Q3 2015 Results, Including Record Net Revenue of Nearly $6.0 Million -- Net Income Up 428% to $410,450

GTX Corp. (GTXO)

The QualityStocks Daily Newsletter would like to spotlight GTX Corp. (GTXO). Today, GTX Corp. closed trading at $0.011, up 10.00%, on 41,700 volume with 4 trades. The stock’s average daily volume over the past 60 days is 601,472, and its 52-week low/high is $0.0084/$0.023.

GTX Corp. (GTXO), through its robust IoT enterprise monitoring platform and licensing, subscription recurring revenue business model, offers a complete end-to-end solution backed by an extensive portfolio of patents with filing dates going back as early as 2002, patents pending, registered trademarks, copy rights and URLs. GTX was featured in a 38-page research piece outlining the value proposition of the company's IP portfolio, and was also published in a SeeThruEquity research report discussing the value of the company's IP.

GTX has established a growing global distribution network with partners in more than 20 countries, and has garnered millions of dollars' worth of free media with coverage on CNN, Good Morning America, The Doctors, Fox News, Discovery Channel, ABC, NBC, CBS, The New York Times, LA Times, U.S.A. Today, the LA Business Journal, AARP and hundreds of other television, radio, magazine and newspaper media outlets across the globe.

The company's flagship, patented GPS SmartSoles were recently showcased in Munich at the Telefonica Digital Innovation Day 2015; was featured in AARP's 2015 technology gear guide; and came in second place, with Microsoft finishing first and Samsung taking third, in the 2015 Wearables, Health, Fitness & Wellness category at CTIA's Hot for the Holidays Awards competition.

As GTX continues to expand its brand awareness and distribution channels both domestically and internationally, in parallel it also plans to introduce new products with an emphasis on e-health and wellness. Corporate strategies are guided by a visionary management team with the insight and experience needed to navigate the plentiful opportunities and potential market share in the emerging multibillion IoT and Wearable Tech industries.

"With approximately 2% of the population having been diagnosed with Alzheimer's, dementia, autism, TBI or some other cognitive disorder which may lead to wandering due to memory loss, GTX plays a vital role in the safety, security and recovery of these individuals and their caregivers." --- Patrick Bertagna GTX Corp CEO. Disclaimer

GTX Corp. Company Blog

GTX Corp. News:

GTX Corp. Launches New Track My Workforce Mobile App and Tracking Portal

GTX Corp (GTXO) CEO Featured in Exclusive QualityStocks Interview

GTX Corp Reports Third Quarter 2015 Financial Results and Business Overview


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Wall Street Resources


INO.com Market Report


Wall Street Resources

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251